Latest Articles

Publication Date
Molecular and Immune Microenvironmental Changes Across Endometrial Lesions: A Comprehensive Immunohistochemical and Clinical Analysis of Progression From Benignity to Carcinoma.

Adenomyosis and endometriosis are estrogen-driven disorders with a recognized potential for malignant transformation, particularly through atypical endometriosis. The molecular and immune mechanisms underlying this progression remain incompletely understood. However, clinical …

Published: Dec. 24, 2025, midnight
The Histamine-Associated Inflammatory Landscape of Endometriosis: Molecular Profiling of HDC, HRH1-HRH4, and Cytokines Across Lesion Subtypes.

Pain in endometriosis involves not only nociceptive but also neuropathic and neurogenic components, reflecting its complex nature. Histamine, a biogenic amine, has emerged as a critical mediator connecting inflammation and …

Published: Dec. 24, 2025, midnight
Study Explores Cancer-Like Traits in Endometriosis Including Abnormal Cell Growth and Tissue Invasion - geneonline.com

Study Explores Cancer-Like Traits in Endometriosis Including Abnormal Cell Growth and Tissue Invasion geneonline.com

Published: Dec. 23, 2025, 8:37 p.m.
Endometriosis: Unveiling Its Cancer Hallmarks - BIOENGINEER.ORG

Endometriosis: Unveiling Its Cancer Hallmarks BIOENGINEER.ORG

Published: Dec. 23, 2025, 8:14 p.m.
Endometriosis: Unveiling Its Cancer Hallmarks - Bioengineer.org

Endometriosis: Unveiling Its Cancer Hallmarks Bioengineer.org

Published: Dec. 23, 2025, 8:14 p.m.
Targeting DPP4: Ferroptosis and Endometrial Receptivity in PCOS - BIOENGINEER.ORG

Targeting DPP4: Ferroptosis and Endometrial Receptivity in PCOS BIOENGINEER.ORG

Published: Dec. 23, 2025, 7:31 p.m.
Targeting DPP4: Ferroptosis and Endometrial Receptivity in PCOS - Bioengineer.org

Targeting DPP4: Ferroptosis and Endometrial Receptivity in PCOS Bioengineer.org

Published: Dec. 23, 2025, 7:31 p.m.
Phase 3 Trial of T-DXd Initiated in HER2+ Endometrial Cancer - Targeted Oncology

Phase 3 Trial of T-DXd Initiated in HER2+ Endometrial Cancer Targeted Oncology

Published: Dec. 23, 2025, 2:07 p.m.
Endometriosis Treatment Market Size in the 7MM was USD 2,300 - openPR.com

Endometriosis Treatment Market Size in the 7MM was USD 2,300 openPR.com

Published: Dec. 23, 2025, 11:56 a.m.
Endometriosis Drugs Market: Strategic Growth and Future Scope - openPR.com

Endometriosis Drugs Market: Strategic Growth and Future Scope openPR.com

Published: Dec. 23, 2025, 11:29 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!